Section
Negotiations
PBM contracts, formulary dynamics, and the terms that matter
Negotiations
By shifting step therapy policy on high-cost biologics, Aetna has upended specialty drug contracting -and set …
Negotiations
Nearly $19B in annual copay assistance is up for grabs as insurers and drugmakers escalate their fight over ac…
Negotiations
Behind closed doors, PBM rebate talks resemble a competitive auction, deciding which drugs make the formulary …
Negotiations
ESI moved 47 products across tiers in its mid-year formulary update, the largest mid-cycle adjustment in five …
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.